Therefore the role of NF-κB pathway downstream of both HER2 and uPAR assumes significance not only due to the part it plays in tumor initiation, metastasis and recurrence of disease condition with increased aggressiveness, but also from reports that implicate NF-κB to the expansion of CSCs. Here, ERBB2 is linked to neoplasm.